These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35683561)

  • 21. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 22. Surgical outcomes of gastro-entero-pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma.
    Li MX; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Zhang XF; Pawlik TM
    J Surg Oncol; 2022 Sep; 126(4):689-697. PubMed ID: 35616186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of radical surgical treatment in the management of 58 locally advanced rectal neuroendocrine neoplasms, one multicenter retrospective study.
    Wang Z; Liu Z; Wen Z; Li R; An K; Mei S; Chen J; Shen H; Li J; Zhao F; Wei F; Xiao T; Liu Q
    Eur J Surg Oncol; 2021 Dec; 47(12):3166-3174. PubMed ID: 34294465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.
    Qiu MJ; Chen YB; Bi NR; Yang SL; He XX; Xiong ZF
    Dis Markers; 2018; 2018():9191639. PubMed ID: 30416612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs.
    Shi M; Fan Z; Xu J; Yang J; Li Y; Gao C; Su P; Wang X; Zhan H
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188637. PubMed ID: 34678439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
    Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
    Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification.
    Xu JX; Wu DH; Ying LW; Hu HG
    World J Gastroenterol; 2021 Dec; 27(47):8123-8137. PubMed ID: 35068858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grading of Neuroendocrine Carcinomas: Correlation of
    Liverani C; Bongiovanni A; Mercatali L; Foca F; Pieri F; De Vita A; Spadazzi C; Miserocchi G; Recine F; Riva N; Nicolini S; Severi S; Martinelli G; Ibrahim T
    Dis Markers; 2018; 2018():6878409. PubMed ID: 30627226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features.
    Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Klöppel G
    Virchows Arch; 2022 Feb; 480(2):359-368. PubMed ID: 34499237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
    Fazio N; Milione M
    Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment and clinical outcome of nonfunctional pancreatic neuroendocrine tumors: a 14-year experience from one single center.
    Yang M; Zeng L; Zhang Y; Su AP; Yue PJ; Tian BL
    Medicine (Baltimore); 2014 Nov; 93(22):e94. PubMed ID: 25396335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grading the neuroendocrine tumors of the lung: an evidence-based proposal.
    Rindi G; Klersy C; Inzani F; Fellegara G; Ampollini L; Ardizzoni A; Campanini N; Carbognani P; De Pas TM; Galetta D; Granone PL; Righi L; Rusca M; Spaggiari L; Tiseo M; Viale G; Volante M; Papotti M; Pelosi G
    Endocr Relat Cancer; 2014 Feb; 21(1):1-16. PubMed ID: 24344249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.
    Klöppel G
    Visc Med; 2017 Oct; 33(5):324-330. PubMed ID: 29177160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
    Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
    BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Quantification of
    Lee H; Nakamoto R; Moore SE; Pantel AR; Eads JR; Aparici CM; Pryma DA
    Acad Radiol; 2022 Sep; 29(9):1308-1316. PubMed ID: 34836776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis.
    Ziogas IA; Tasoudis PT; Borbon LC; Sherman SK; Breheny PJ; Chandrasekharan C; Dillon JS; Bellizzi AM; Howe JR
    Ann Surg Oncol; 2023 Jan; 30(1):148-160. PubMed ID: 36227392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
    Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
    Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.